Evofem Biosciences, Inc.
General ticker "EVFM" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.3M (TTM average)
Evofem Biosciences, Inc. follows the US Stock Market performance with the rate: 28.0%.
Estimated limits based on current volatility of 9.5%: low 0.01$, high 0.01$
Factors to consider:
- Total employees count: 38 (+8.6%) as of 2023
- Top business risk factors: Bankruptcy risk, Liquidity and credit risks, Acquisition/divestiture risks, Internal control weaknesses, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.01$, 0.04$]
- 2025-12-31 to 2026-12-31 estimated range: [0.01$, 0.04$]
Financial Metrics affecting the EVFM estimates:
- Positive: with PPE of -0.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Inventory ratio change, % of -0.99 <= -0.75
- Negative: Operating cash flow per share per price, % of -426.96 <= 0.33
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term EVFM quotes
Long-term EVFM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $16.84MM | $18.22MM | $19.36MM |
| Operating Expenses | $100.96MM | $36.06MM | $27.04MM |
| Operating Income | $-84.12MM | $-17.85MM | $-7.68MM |
| Non-Operating Income | $7.47MM | $70.84MM | $-1.18MM |
| R&D Expense | $25.03MM | $2.94MM | $1.84MM |
| Income(Loss) | $-76.65MM | $53.00MM | $-8.86MM |
| Taxes | $0.04MM | $0.02MM | $0.00MM |
| Profit(Loss)* | $-76.70MM | $52.98MM | $-8.86MM |
| Stockholders Equity | $-71.80MM | $-66.51MM | $-71.26MM |
| Inventory | $5.38MM | $1.70MM | $1.58MM |
| Assets | $25.16MM | $10.55MM | $23.79MM |
| Operating Cash Flow | $-70.41MM | $-8.97MM | $-3.88MM |
| Capital expenditure | $0.34MM | $0.00MM | $0.01MM |
| Investing Cash Flow | $-0.34MM | $-0.00MM | $-0.57MM |
| Financing Cash Flow | $61.94MM | $4.78MM | $4.62MM |
| Earnings Per Share** | $-164.59 | $10.98 | $-0.09 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.